Bow River LLC has a total of 22 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, United States and Canada. Its main competitors in its focus markets pharmaceuticals are DONG XINFANG, CANNTAB THERAPEUTICS LTD and LU DAOZONG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 8 | |
#2 | United States | 6 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Republic of Korea | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Chow Christina | 22 |
#2 | Srinivasan Sundar | 22 |
Publication | Filing date | Title |
---|---|---|
US2019262328A1 | Methods of treatment | |
US2019076425A1 | Methods of treatment with CYP3A4 substrate drugs | |
CA3062770A1 | Use of a cyp3a4 substrate drug with a cyp3a4 substrate inhibitor |